The first quarter of 2018 report of Jianfeng Group
Release time:
2021-01-05
公司代码:600668 公司简称:尖峰集团
浙江尖峰集团股份有限公司
2018年第一季度报告正文
一、 重要提示
1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
1.2 公司全体董事出席董事会审议季度报告。
1.3 公司负责人蒋晓萌、主管会计工作负责人兰小龙及会计机构负责人(会计主管人员)吴德富保证季度报告中财务报表的真实、准确、完整。
1.4 本公司第一季度报告未经审计。
二、 公司主要财务数据和股东变化
2.1 主要财务数据
单位:元 币种:人民币
|
|
本报告期末 |
上年度末 |
本报告期末比上年度末增减(%) |
|
总资产 |
4,366,775,455.41 |
4,175,730,846.73 |
4.58 |
|
归属于上市公司股东的净资产 |
2,757,802,176.89 |
2,627,318,888.65 |
4.97 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
经营活动产生的现金流量净额 |
13,967,176.23 |
317,755.25 |
4,295.58 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
营业收入 |
669,522,008.06 |
566,846,953.96 |
18.11 |
|
归属于上市公司股东的净利润 |
104,344,646.12 |
112,200,485.23 |
-7.00 |
|
归属于上市公司股东的扣除非经常性损益的净利润 |
98,932,514.65 |
108,827,872.82 |
-9.09 |
|
加权平均净资产收益率(%) |
3.89 |
4.57 |
减少0.68个百分点 |
|
基本每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
|
稀释每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
非经常性损益项目和金额
单位:元 币种:人民币
|
项目 |
本期金额 |
说明 |
|
非流动资产处置损益 |
-25,888.87 |
|
|
越权审批,或无正式批准文件,或偶发性的税收返还、减免 |
|
|
|
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国家政策规定、按照一定标准定额或定量持续享受的政府补助除外 |
6,648,601.60 |
|
|
委托他人投资或管理资产的损益 |
270,624.68 |
|
|
除上述各项之外的其他营业外收入和支出 |
-166,308.37
|
|
|
少数股东权益影响额(税后) |
-196,583.34 |
|
|
所得税影响额 |
-1,118,314.23 |
|
|
合计 |
5,412,131.47 |
|
2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
单位:股
|
股东总数(户) |
27,298 |
||||||
|
前十名股东持股情况 |
|||||||
|
股东名称(全称) |
期末持股 数量 |
比例(%) |
持有有限售条件股份数量 |
质押或冻结情况 |
股东性质 |
||
|
股份状态 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
16.15 |
0 |
无 |
0 |
国有法人 |
|
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
4.99 |
0 |
无 |
0 |
未知 |
|
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
3.68 |
0 |
无 |
0 |
未知 |
|
|
香港中央结算有限公司 |
4,372,091 |
1.27 |
0 |
无 |
0 |
未知 |
|
|
刘锦春 |
3,874,269 |
1.13 |
0 |
无 |
0 |
境内自然人 |
|
|
钟以隆 |
3,584,000 |
1.04 |
0 |
无 |
0 |
境内自然人 |
|
|
苏志伟 |
3,226,848 |
0.94 |
0 |
无 |
0 |
境内自然人 |
|
|
王晓红 |
3,121,943 |
0.91 |
0 |
无 |
0 |
境内自然人 |
|
|
骆惠娟 |
2,726,200 |
0.79 |
0 |
无 |
0 |
境内自然人 |
|
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
0.78 |
0 |
无 |
0 |
未知 |
|
|
前十名无限售条件股东持股情况 |
|||||||
|
股东名称 |
持有无限售条件流通股的数量 |
股份种类及数量 |
|||||
|
种类 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
人民币普通股 |
55,564,103 |
||||
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
人民币普通股 |
17,158,922 |
||||
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
人民币普通股 |
12,665,208 |
||||
|
香港中央结算有限公司 |
4,372,091 |
人民币普通股 |
4,372,091 |
||||
|
刘锦春 |
3,874,269 |
人民币普通股 |
3,874,269 |
||||
|
钟以隆 |
3,584,000 |
人民币普通股 |
3,584,000 |
||||
|
苏志伟 |
3,226,848 |
人民币普通股 |
3,226,848 |
||||
|
王晓红 |
3,121,943 |
人民币普通股 |
3,121,943 |
||||
|
骆惠娟 |
2,726,200 |
人民币普通股 |
2,726,200 |
||||
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
人民币普通股 |
2,667,200 |
||||
|
上述股东关联关系或一致行动的说明 |
本公司第一大股东通济国投与其他上述第2名至第10名无限售条件股东之间不存在关联关系。公司未知其他9名股东之间是否存在关联关系,也未知是否属于《上市公司收购管理办法》规定的一致行动人。 |
||||||
|
表决权恢复的优先股股东及持股数量的说明 |
不适用 |
||||||
2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情况表
三、 重要事项
3.1 公司主要会计报表项目、财务指标重大变动的情况及原因
|
单位:万元 |
||||
|
资产负债表项目 |
期末数 |
期初数 |
变动幅度 |
变动原因 |
|
预付款项 |
9,726.83 |
4,610.82 |
110.96% |
主要系本报告期子公司预付货款增加所致。 |
|
应收股利 |
2,076.00 |
|
100.00% |
主要系报告期公司按被投资单位天士力控股集团有限公司2017年度利润分配的股东会决议计入应收的现金股利所致。 |
|
其他应收款 |
1,997.52 |
1,308.75 |
52.63% |
主要系报告期公司及子公司存出保证金增加所致。 |
|
其他流动资产 |
925.10 |
1,328.92 |
-30.39% |
主要系报告期子公司抵扣了上年取得的留抵进项税所致。 |
|
短期借款 |
16,800.00 |
8,900.00 |
88.76% |
主要系报告期公司银行贷款增加所致。 |
|
应付职工薪酬 |
1,279.67 |
3,627.55 |
-64.72% |
主要系报告期公司及子公司发放上年末计提的年终奖所致。 |
|
应付利息 |
1,579.21 |
934.17 |
69.05% |
主要系报告期公司计提应付债券利息以及由于银行借款增加相应计提利息增加所致。 |
|
应付股利 |
2,520.16 |
120.16 |
1997.38% |
主要系报告期子公司股东会决议已宣告发放2017年度现金股利所致。 |
|
利润表项目 |
本期数 |
上年同期数 |
变动幅度 |
变动原因 |
|
税金及附加 |
551.67 |
336.88 |
63.76% |
主要系报告期子公司应交税费增加所致。 |
|
销售费用 |
10,678.03 |
4,772.03 |
123.76% |
主要系报告期子公司尖峰药业销售收入的增长和销售模式的调整,公司销售费用中增加了市场推广费和其他支出。 |
|
投资收益 |
1,950.22 |
6,087.10 |
-67.96% |
主要系报告期公司联营投资单位天士力控股集团有限公司利润大幅减少,公司权益法核算计入投资收益相应减少所致。 |
|
其他收益 |
502.73 |
0.00 |
100.00% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助从“营业外收入”科目转入所致。 |
|
营业外收入 |
171.06 |
485.84 |
-64.79% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助转入“其他收益”项目所致。 |
|
营业外支出 |
27.23 |
4.66 |
483.87% |
主要系报告期子公司营业外支出增加所致。 |
|
所得税费用 |
3,098.44 |
1,981.63 |
56.36% |
主要系本报告期子公司实现的利润总额增加相应的所得税费用增加所致。 |
|
现金流量表项目 |
|
|
|
|
|
经营活动产生的现金流量净额 |
1,396.72 |
31.78 |
4295.58% |
主要系报告期由于公司经营活动现金流入增加所致。 |
|
投资活动产生的现金流量净额 |
-9,823.08 |
-2,287.17 |
|
主要系报告期子公司对外投资及在建项目投入增加所致。 |
|
筹资活动产生的现金流量净额 |
7,779.59 |
-210.06 |
|
主要系报告期公司增加了银行借款所致。 |
3.2 重要事项进展情况及其影响和解决方案的分析说明
1、2017年2月28日,公司九届10次董事会通过了《关于子公司对外投资的议案》,公司控股子公司尖峰药业拟以增资和股权转让的方式分期对北慧生物进行投资;2018年3月31日,公司披露了对外投资进展情况。上述事项详见2017年3月1日、2018年3月31日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2017-003《关于子公司对外投资的公告》、临2018-003《关于子公司对外投资的进展公告》。
2、2018年1月19日,本公司十届2次董事会通过了《关于子公司尖峰药业对外投资的议案》,尖峰药业拟投资11132.79万元以收购股份和增资的方式对上海北卡进行投资。投资完成后,上海北卡注册资本由原来的1100万元增加至1755.55万元,其中尖峰药业占55%。上述事项详见2018年1月20日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-002《关于子公司尖峰药业对外投资的公告》。截止报告期末,尖峰药业已经按照协议约定,支付了第一期股权转让款和增资款。目前正在办理资产交接、工商变更登记手续。
3、2017年4月15日,公司九届11次董事会通过了《关于尖峰国贸新建仓库(电商物流园)项目的议案》,批准控股子公司尖峰国贸投资7500万元新建仓库(电商物流园)。2017年6月6日,公司九届13次董事会通过了《关于尖峰国贸仓库出租的议案》,同意尖峰国贸将该新建仓库(电商物流园)的仓库、堆场、停车场等物业出租给上海安能聚创供应链管理有限公司。上述事项详见2017年4月18日、2017年6月7日披露于上海证券交易所网站(http//:www.sse.com.cn/) 的临2017-006《九届11次董事会决议公告》和临2017-013《九届13次董事会决议公告》。截止3月底,该项目累计已投入资金3909.65万元。
3.3 报告期内超期未履行完毕的承诺事项
3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警示及原因说明
|
公司名称 |
浙江尖峰集团股份有限公司 |
|
法定代表人 |
蒋晓萌 |
|
日期 |
2018年4月27日 |
- 发布时间: 2018-04-28
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31